| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
35,915,000 |
| Market
Cap: |
4.57(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$36.74 - $124.44 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile TransMedics Group is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across various disease states. Co. has developed the Organ Care System (OCS), a portable organ perfusion and monitoring system that using Co.'s technology to replicate near-physiologic conditions for donor organs outside of the human body. The OCS was designed to perfuse donor organs with warm, oxygenated and nutrient-enriched blood, while maintaining the organs in a living, functioning state; the lung is breathing, the heart is beating and the liver is producing bile. Co.'s OCS products are one for each of lung, heart and liver transplantations.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
2,500 |
2,500 |
| Total Buy Value |
$0 |
$0 |
$155,000 |
$155,000 |
| Total People Bought |
0 |
0 |
1 |
1 |
| Total Buy Transactions |
0 |
0 |
1 |
1 |
| Total Shares Sold |
271,054 |
342,899 |
405,806 |
1,060,395 |
| Total Sell Value |
$27,491,657 |
$33,196,965 |
$37,923,912 |
$74,654,923 |
| Total People Sold |
4 |
6 |
6 |
10 |
| Total Sell Transactions |
21 |
30 |
40 |
119 |
| End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Basile Edward M |
|
– • – |
2023-05-25 |
4 |
A |
$0.00 |
$0 |
D/D |
1,193 |
15,507 |
|
- |
|
| Weill David |
|
– • – |
2023-05-25 |
4 |
A |
$0.00 |
$0 |
D/D |
1,193 |
11,193 |
|
- |
|
| Raines Merilee |
|
– • – |
2023-05-25 |
4 |
A |
$0.00 |
$0 |
D/D |
1,193 |
1,193 |
|
- |
|
| Gunderson Thomas James |
|
– • – |
2023-05-25 |
4 |
A |
$0.00 |
$0 |
D/D |
1,193 |
1,193 |
|
- |
|
| Tobin James R |
|
– • – |
2023-05-25 |
4 |
A |
$0.00 |
$0 |
D/D |
1,193 |
1,193 |
|
- |
|
| Lovell Stephanie |
|
– • – |
2023-05-25 |
4 |
A |
$0.00 |
$0 |
D/D |
1,193 |
1,193 |
|
- |
|
| Kania Edwin M Jr |
|
– • – |
2023-05-25 |
4 |
A |
$0.00 |
$0 |
D/D |
1,193 |
257,944 |
|
- |
|
| Gordon Stephen |
Chief Financial Officer |
• – – |
2023-05-01 |
4 |
AS |
$79.05 |
$395,250 |
D/D |
(5,000) |
18,789 |
|
-25% |
|
| Gordon Stephen |
Chief Financial Officer |
• – – |
2023-05-01 |
4 |
OE |
$16.14 |
$80,700 |
D/D |
5,000 |
23,789 |
|
- |
|
| Hassanein Waleed H |
President & CEO |
• • – |
2023-05-01 |
4 |
AS |
$77.84 |
$585,989 |
D/D |
(7,500) |
559,191 |
|
-25% |
|
| Khayal Tamer I |
Chief Commercial Officer |
• – – |
2023-04-21 |
4 |
AS |
$90.04 |
$249,861 |
I/I |
(2,775) |
17,001 |
|
-26% |
|
| Khayal Tamer I |
Chief Commercial Officer |
• – – |
2023-04-21 |
4 |
AS |
$85.44 |
$1,037,626 |
D/D |
(12,026) |
14,375 |
|
-26% |
|
| Khayal Tamer I |
Chief Commercial Officer |
• – – |
2023-04-21 |
4 |
OE |
$16.14 |
$194,100 |
D/D |
12,026 |
26,401 |
|
- |
|
| Hassanein Waleed H |
President & CEO |
• • – |
2023-03-10 |
4 |
OE |
$2.21 |
$426,694 |
D/D |
193,074 |
574,191 |
|
- |
|
| Hassanein Waleed H |
President & CEO |
• • – |
2023-03-01 |
4 |
AS |
$80.17 |
$605,391 |
D/D |
(7,500) |
381,117 |
|
7% |
|
| Basile Edward M |
Director |
– • – |
2023-03-01 |
4 |
S |
$80.10 |
$280,350 |
D/D |
(3,500) |
14,314 |
|
-7% |
|
| Gordon Stephen |
Chief Financial Officer |
• – – |
2023-03-01 |
4 |
AS |
$79.51 |
$397,550 |
D/D |
(5,000) |
18,789 |
|
7% |
|
| Gordon Stephen |
Chief Financial Officer |
• – – |
2023-03-01 |
4 |
OE |
$16.14 |
$80,700 |
D/D |
5,000 |
23,789 |
|
- |
|
| Kania Edwin M Jr |
Director |
– • – |
2023-02-28 |
4 |
A |
$79.76 |
$19,339,966 |
D/D |
242,477 |
256,751 |
|
- |
|
| Khayal Tamer I |
Chief Commercial Officer |
• – – |
2023-02-28 |
4 |
AS |
$80.06 |
$400,300 |
I/I |
(5,000) |
19,776 |
|
8% |
|
| Khayal Tamer I |
Chief Commercial Officer |
• – – |
2023-02-28 |
4 |
AS |
$80.15 |
$801,500 |
D/D |
(10,000) |
14,375 |
|
8% |
|
| Khayal Tamer I |
Chief Commercial Officer |
• – – |
2023-02-28 |
4 |
OE |
$16.14 |
$161,400 |
D/D |
10,000 |
24,375 |
|
- |
|
| Basile Edward M |
|
– • – |
2023-02-27 |
4 |
S |
$76.20 |
$390,315 |
D/D |
(5,000) |
17,814 |
|
-5% |
|
| Weill David |
|
– • – |
2023-02-27 |
4 |
S |
$76.51 |
$455,100 |
D/D |
(5,934) |
10,000 |
|
-5% |
|
| Weill David |
|
– • – |
2023-02-27 |
4 |
OE |
$14.20 |
$84,263 |
D/D |
5,934 |
15,934 |
|
- |
|
358 Records found
|
|
Page 4 of 15 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
5.37 (4.05%) 
